Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors

Brain Tumor Pathology

Volumn 33, Issue 2, 2016, Pages 117-128

  Sharma, Vikas ^a   Purkait, Suvendu ^a   Takkar, Sonam ^b   Malgulwar, Prit Benny ^a   Kumar, Anupam ^a   Pathak, Pankaj ^a   Suri, Vaishali ^a   Sharma, Mehar C ^a   Suri, Ashish ^a   Kale, Shashank Sharad ^a   Kulshreshtha, Ritu ^b   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Astrocytic tumors; EZH2; Glioblastoma; MicroRNAs

Indexed keywords

HISTONE H3; MICRORNA; MICRORNA 26A 5P; MICRORNA 27A 3P; MICRORNA 498; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; EZH2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; DOWN REGULATION; GENE TARGETING; HISTONE MODIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA ANALYSIS; SIGNAL TRANSDUCTION; BRAIN NEOPLASMS; CANCER STAGING; DISEASE COURSE; EPISTASIS; FEMALE; GENE EXPRESSION; GENETICS; GLIOBLASTOMA; METABOLISM; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE PROGRESSION; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; YOUNG ADULT;

EID: 84953384242     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-015-0245-1     Document Type: Article

References (41)

1. McNamara M, Sahebjam S, Mason W (2013) Emerging biomarkers in glioblastoma. Cancer (Basel) 5:1103–1119
2. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
3. Bracken AP, Helin K (2009) Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9:773–784
4. Purkait S, Sharma V, Jha P et al (2015) EZH2 expression in gliomas: correlation with CDKN2A gene deletion/p16 loss and MIB-1 proliferation index. Neuropathology 35:421–431
5. Suvà M-L, Riggi N, Janiszewska M et al (2009) EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res 69:9211–9218
6. Orzan F, Pellegatta S, Poliani PL et al (2011) Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol 37:381–394
7. Li G, Warden C, Zou Z et al (2013) Altered expression of polycomb group genes in glioblastoma multiforme. PLoS One 8:e80970
8. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells microRNA-21 is an antiapoptotic factor in human. Cancer Res 65:6029–6033
9. Ciafrè SA, Galardi S, Mangiola A et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351–1358
10. Silber J, Lim DA, Petritsch C et al (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14. doi:10.1186/1741-7015-6-14
11. Godlewski J, Nowicki MO, Bronisz A et al (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by MicroRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68:9125–9130
12. Malzkorn B, Wolter M, Liesenberg F et al (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20:539–550
13. Li Mengfeng, Li Jun, Liu Lei et al (2013) MicroRNA in human glioma. Cancers 5(4):1306–1331
14. Rao SAM, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol Off J United States Can Acad Pathol Inc Pathol 23:1404–1417
15. Varambally S, Cao Q, Mani R-S et al (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Sci 322:1695–1699
16. Gandellini P, Folini M, Longoni N et al (2009) miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cε. Cancer Res 69:2287–2295
17. Cao P, Deng Z, Wan M et al (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 9:108
18. Tzatsos A, Paskaleva P, Lymperi S et al (2011) Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells. J Biol Chem 286:33061–33069
19. Kottakis F, Polytarchou C, Foltopoulou P et al (2011) FGF-2 regulates cell proliferation, migration and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell 43:285–298
20. Cao Q, Mani R-S, Ateeq B et al (2011) Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 20:187–199
21. Valente V, Teixeira SA, Neder L et al (2009) Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol 10:17
22. Kleer CG, Cao Q, Varambally S et al (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci 100:11606–11611
23. Batlle E, Sancho E, Franci C et al (2000) The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84–89
24. Zhang J, Chen L, Han L et al (2015) EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Lett 356:929–936
25. Suh S-S, Yoo JY, Nuovo GJ et al (2012) MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci 109:5316–5321
26. Xu W, Liu M, Peng X et al (2013) MiR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42:757–766
27. Ge YF, Sun J, Jin CJ et al (2013) AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo. Asian Pacific J Cancer Prev 14:963–968
28. Guo P, Nie Q, Lan J et al (2013) C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells. Biochem Biophys Res Commun 441:186–190
29. Guo P, Lan J, Ge J et al (2014) MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia–telangiectasia mutated. Exp Cell Res 320:200–208
30. Smits M, Nilsson J, Mir SE et al (2010) miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1:710–720
31. Yao Y-L, Ma J, Wang P et al (2015) miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. CNS Neurosci Ther 21:40–51
32. Lv Z, Yang L (2013) MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep 8:345–349
33. Chen Q, Lu G, Cai Y et al (2014) MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1. Neuro-Oncology 16:637–651
34. Bier A, Giladi N, Kronfeld N et al (2013) MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4:665–676
35. Qiu S, Huang D, Yin D et al (2013) Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Biochim Biophys Acta Mol Basis Dis 1832:1697–1707
36. Hausser J, Zavolan M (2014) Identification and consequences of miRNA-target interactions—beyond repression of gene expression. Nat Rev Genet 15:599–612
37. Gao J, Liu QG (2011) The role of miR-26 in tumors and normal tissues (Review). Oncol Lett 2:1019–1023
38. Huse JT, Brennan C, Hambardzumyan D et al (2009) The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23:1327–1337
39. Kim H, Huang W, Jiang X et al (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci 107:2183–2188
40. Visani M, de Biase D, Marucci G et al (2014) Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III. Mol Oncol 8:417–430
41. Iliopoulos D, Lindahl-Allen M, Polytarchou C et al (2010) Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39:761–772